Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
|
By HospiMedica International staff writers Posted on 23 Jun 2022 |
|
Manufacturers and players in the global hospital microbiology testing market offer various types of tests, including fungal, viral, and bacterial, as well as instruments and consumables to their end users, i.e. hospitals and clinics. Some of the leading procedures adopted in the global hospital microbiology testing market include microscopy, molecular diagnostics, microbial culture, and biochemical tests. Among the various segments, the respiratory diseases segment leads the global hospital microbiology testing market in terms of demand, owing to the increasing prevalence of asthma as well as the reduction in air quality, causing various respiratory illnesses among the general population globally. Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company.
Increasing availability as well as efficacy of various anti-viral treatment therapeutics, aimed at the treatment of disorders such as gingivitis, COPD or chronic pulmonary obstructive disease, and periodontitis, among others, is driving the growth of the global hospital microbiology testing market. Furthermore, the increasing prevalence of various sexually transmitted infections is also generating high demand in the global hospital microbiology testing market. As a result, an increase in awareness related to sex and sexuality in various emerging countries is contributing to the market growth. Additionally, growing investments aimed at furthering microbiology testing solutions and relevant equipment is expected to support the development of the global hospital microbiology testing market over the coming years.
Geographically, North America holds the largest share of the global hospital microbiology testing market, mainly due to the increasing prevalence of various chronic as well as acute diseases, presence of well-established and technology-enabled healthcare infrastructure, and rising demand for technologically-advanced and accurate diagnostic testing capabilities in the region. Europe holds the second-largest share of the global hospital microbiology testing market, although the emerging nations in Asia Pacific are expected to provide lucrative growth and expansion opportunities for market growth over the coming years. The growing importance of medical tourism, new and favorable reimbursement policies and tax benefits are propelling the growth of the hospital microbiology testing market in the Asia Pacific region.
Related Links:
Transparency Market Research
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
